Showing 2,660 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

Defuse Hepatitis C, the Viral Time Bomb: Test and Treat Hepatitis C

Editor's pick
Treatment Action Group
21 May 2014
Hepatitis C treatment

US health insurers say Gilead hepatitis C drug too costly

Editor's pick
Reuters
21 May 2014
New & experimental hepatitis C treatment

OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection

Editor's pick
Reuters
16 May 2014
Prisoners

To curb hepatitis C, test and treat inmates

Editor's pick
Eurekalert Inf Dis
15 May 2014
Alcohol

Even moderate drinking increases risk of advanced liver fibrosis for people with HIV and HCV co-infection

News
12 May 2014
New & experimental hepatitis C treatment

AbbVie Submits for EU Marketing Authorization its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Chronic Hepatitis C

Editor's pick
AbbVie press release
8 May 2014
Hepatitis C treatment

Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation

News
8 May 2014
Hepatitis C treatment

ITPCru report: Access to drugs for treating hepatitis C in Russia in 2013

Editor's pick
EATG
8 May 2014
Hepatitis C treatment

Janssen submits US FDA new drug application for simeprevir / sofosbuvir combination use

Editor's pick
Janssen press release
8 May 2014
Access to healthcare

UNITAID approves grants of $160 million, for hepatitis C, MDR-TB and malaria drugs

Editor's pick
UNITAID
7 May 2014
Hepatitis C transmission & prevention

UK - 'Eradicating hepatitis C is a realistic aim'

Editor's pick
Health Service Journal
6 May 2014
Hepatitis C treatment

Sustained response to treatment reduces fatigue in hepatitis C patients

News
6 May 2014
Pharmaceutical industry

Vertex ends hepatitis C investment as sales fall

Editor's pick
CNBC
2 May 2014
Hepatitis C treatment

Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4

News
2 May 2014
Hepatitis B

Hepatitis B a growing problem in UK prisons

Editor's pick
The Independent
1 May 2014
Elimination of hepatitis C

Eliminating Hepatitis C Within a Generation. What are you going to do about it?

Editor's pick
You Tube / Jon Derricott
30 April 2014
Pharmaceutical industry

Biotech’s Hard Bargain

Editor's pick
The New Yorker
24 April 2014
Hepatitis B

Anti-HBV antiretrovirals may help ward off HBV infection in MSM

Editor's pick
International AIDS Society
24 April 2014
Harm reduction

Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users

Editor's pick
Infectious Disease Special Edition
24 April 2014
Hepatitis C transmission & prevention

Studies investigate presence of hepatitis C virus among gay and bisexual men

Editor's pick
CATIE
24 April 2014
New & experimental hepatitis C treatment

Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence

News
23 April 2014
New & experimental hepatitis C treatment

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Editor's pick
AbbVie press release
23 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Hepatitis C treatment

Sofosbuvir for hepatitis C works well despite multiple negative predictive factors

News
23 April 2014